A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients. Doctors share what patients should know about the drug.
Two leading drug experts set out a road map to reverse the opioid epidemic in 2016. This is how we've progressed since then.
Attention-deficit/hyperactivity disorder (ADHD) causes symptoms that begin in early childhood. Though ADHD is often diagnosed between the ages of four and seven, it ...
The Biden administration Wednesday finalized a long-awaited rule laying out how some health care providers can prescribe gold-standard opioid use disorder treatments through telehealth.
The DEA’s final rule for the telemedicine prescribing of buprenorphine will enable practitioners to prescribe a six-month initial supply of Schedule III-V medications to treat opioid use disorder via ...
A quantitative alcohol history should be recorded for all patients, because alcohol use contributes to many physical and mental disorders ... of endogenous opioids, γ-aminobutyric acid (GABA ...
BEND, Ore. (KTVZ) -- Deschutes County Health Services launched on Wednesday a countywide campaign, Friends for Life, intended to raise public awareness about opioid and fentanyl use and to help ...
Buprenorphine maintenance combined with medical counseling (BUP+MC) is an effective treatment for opioid use disorder (OUD), according to study results published in JAMA Psychiatry. Additionally ...
He argues they will be left at an increased risk of a fatal opioid poisoning without a designated space to use illicit drugs under medical supervision and immediate help to reverse an overdose.
Purdue Pharma’s Sackler family owners are offering to increase their financial contribution to a bankruptcy settlement of opioid lawsuits while accepting some exposure to future litigation ...
Changes in opioid use outcomes after passage of medical marijuana laws Date: January 13, 2025 Source: Columbia University's Mailman School of Public Health Summary: A new study found no changes in ...
Jan 13 (Reuters) - The Sackler family owners of Purdue Pharma are offering to increase their financial contribution to a bankruptcy settlement of opioid lawsuits, while agreeing to some exposure ...